» Articles » PMID: 31543676

Intestinal Permeability in the Pathogenesis of Liver Damage: From Non-alcoholic Fatty Liver Disease to Liver Transplantation

Overview
Specialty Gastroenterology
Date 2019 Sep 24
PMID 31543676
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

The intimate connection and the strict mutual cooperation between the gut and the liver realizes a functional entity called gut-liver axis. The integrity of intestinal barrier is crucial for the maintenance of liver homeostasis. In this mutual relationship, the liver acts as a second firewall towards potentially harmful substances translocated from the gut, and is, in turn, is implicated in the regulation of the barrier. Increasing evidence has highlighted the relevance of increased intestinal permeability and consequent bacterial translocation in the development of liver damage. In particular, in patients with non-alcoholic fatty liver disease recent hypotheses are considering intestinal permeability impairment, diet and gut dysbiosis as the primary pathogenic trigger. In advanced liver disease, intestinal permeability is enhanced by portal hypertension. The clinical consequence is an increased bacterial translocation that further worsens liver damage. Furthermore, this pathogenic mechanism is implicated in most of liver cirrhosis complications, such as spontaneous bacterial peritonitis, hepatorenal syndrome, portal vein thrombosis, hepatic encephalopathy, and hepatocellular carcinoma. After liver transplantation, the decrease in portal pressure should determine beneficial effects on the gut-liver axis, although are incompletely understood data on the modifications of the intestinal permeability and gut microbiota composition are still lacking. How the modulation of the intestinal permeability could prevent the initiation and progression of liver disease is still an uncovered area, which deserves further attention.

Citing Articles

Carotenoids Improve Obesity and Fatty Liver Disease via Gut Microbiota: A Narrative Review.

Hashemi D, Fard M, Mohammadhasani K, Barati M, Nattagh-Eshtivani E Food Sci Nutr. 2025; 13(3):e70092.

PMID: 40071130 PMC: 11893484. DOI: 10.1002/fsn3.70092.


The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights.

Huang Z, Yao Q, Ma S, Zhou J, Wang X, Meng Q Front Microbiol. 2025; 16:1504395.

PMID: 39944642 PMC: 11814227. DOI: 10.3389/fmicb.2025.1504395.


sp. for the Attenuation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice.

Olotu T, Ferrell J Microorganisms. 2025; 12(12.

PMID: 39770690 PMC: 11728176. DOI: 10.3390/microorganisms12122488.


Bacterial contamination of autologous blood salvaged during deceased donor liver transplantation: a prospective observational study.

Kim D, Han S, Yang J, Kwon J, Choi G, Kim J Sci Rep. 2024; 14(1):26785.

PMID: 39500947 PMC: 11538324. DOI: 10.1038/s41598-024-76476-w.


Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction-associated steatotic liver disease: a comprehensive review.

Ku J, Hsu J, Li Y, Wu L J Gastroenterol Hepatol. 2024; 40(1):33-40.

PMID: 39343617 PMC: 11771549. DOI: 10.1111/jgh.16750.


References
1.
Novacek G, Miehsler W, Wrba F, Ferenci P, Penner E, Vogelsang H . Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol. 1999; 11(3):283-8. DOI: 10.1097/00042737-199903000-00012. View

2.
Schultsz C, van den Berg F, ten Kate F, Tytgat G, Dankert J . The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology. 1999; 117(5):1089-97. DOI: 10.1016/s0016-5085(99)70393-8. View

3.
Guarner C, Runyon B, Heck M, Young S, Sheikh M . Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats. Dig Dis Sci. 1999; 44(10):1957-62. DOI: 10.1023/a:1026649730012. View

4.
Su G, Klein R, Aminlari A, Zhang H, Steinstraesser L, Alarcon W . Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology. 2000; 31(4):932-6. DOI: 10.1053/he.2000.5634. View

5.
Macpherson A, Gatto D, Sainsbury E, Harriman G, Hengartner H, Zinkernagel R . A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science. 2000; 288(5474):2222-6. DOI: 10.1126/science.288.5474.2222. View